Dr. Priya Gomathi Kumaravelu, MD

Dr. Kumaravelu practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Kumaravelu's NPI, 1154514677, was assigned on August 20, 2007. Dr. Kumaravelu graduated from Sri Ramachandra Medical College in 2000. Dr. Kumaravelu's Michigan license number on file is 4301086299.

Dr. Kumaravelu's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Kumaravelu's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Kumaravelu is also affiliated with Santa Clara Valley Medical Center. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Kumaravelu to 3 more hospitals, 3 medical groups, 2 group practices and clinics and 1 physician office, each named with a free account. Dr. Kumaravelu's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kumaravelu practices, 8 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Kumaravelu's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Kumaravelu is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Kumaravelu's licenses on file in 3 states: Michigan, California and Texas.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, deep vein thrombosis (DVT), lung cancer, lymphoma, multiple myeloma and neutropenia among the conditions Dr. Kumaravelu treats.

CMS data shows 1,142 Medicare services from Dr. Kumaravelu across 8 procedure codes in 2024, for 276 Medicare patients. Medicare paid $147,737 for them.

CMS counts 276 Medicare patients who saw Dr. Kumaravelu in 2024. The largest group is 75 to 84, with 107 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 63% are also on Medicaid. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kumaravelu's median patient age at 69, with 62% women.

In 2024, Dr. Kumaravelu wrote 937 Medicare Part D claims for 161 patients. 69% of them were for generic drugs. CMS names the drug for 797 of them, across 25 drugs with 11 or more claims each, at $2,451,452 in total drug cost. In 2023, CMS named 506 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kumaravelu for performance year 2024, reported individually. Dr. Kumaravelu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kumaravelu as offering telehealth.

Dmand AI links 3 papers to Dr. Kumaravelu in 2007. Dr. Kumaravelu's most frequent co-authors are Ashutosh Niraj, MD and Hema Madhavi Vankayala, MD.

CMS Open Payments shows 362 general payments to Dr. Kumaravelu from 53 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,585.

Dmand AI lists 1 award for Dr. Kumaravelu, most recently BENJAMIN J. CORY, MD Award in 2025.

Dr. Kumaravelu graduated from Sri Ramachandra Medical College in 2000.

Dr. Kumaravelu is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.